Symrise AG
SY1: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|mr | LOCK|QRZ | LOCK|vSn>bP@ |
Symrise Earnings: Organic Sales Growth Slows, and Further Normalization Expected in 2025
Symrise delivered fourth-quarter organic sales growth of 0.9%, or 5.9% excluding the hyperinflation-related pricing adjustment. EBITDA margin was up 160 basis points to 20.7%, supported by operating leverage and cost-saving initiatives.
